- Home
- ADT vs IRTC Comparison
ADT vs IRTC Comparison
Compare ADT & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- IRTC
- Stock Information
- Founded
- ADT 1874
- IRTC 2006
- Country
- ADT United States
- IRTC United States
- Employees
- ADT N/A
- IRTC N/A
- Industry
- ADT Diversified Commercial Services
- IRTC Medical/Dental Instruments
- Sector
- ADT Consumer Discretionary
- IRTC Health Care
- Exchange
- ADT Nasdaq
- IRTC Nasdaq
- Market Cap
- ADT 7.1B
- IRTC 5.8B
- IPO Year
- ADT 2018
- IRTC 2016
- Fundamental
- Price
- ADT $8.59
- IRTC $185.29
- Analyst Decision
- ADT Buy
- IRTC Strong Buy
- Analyst Count
- ADT 5
- IRTC 13
- Target Price
- ADT $9.34
- IRTC $184.85
- AVG Volume (30 Days)
- ADT 6.5M
- IRTC 309.7K
- Earning Date
- ADT 11-04-2025
- IRTC 10-30-2025
- Dividend Yield
- ADT 2.53%
- IRTC N/A
- EPS Growth
- ADT N/A
- IRTC N/A
- EPS
- ADT 0.68
- IRTC N/A
- Revenue
- ADT $5,058,741,000.00
- IRTC $657,227,000.00
- Revenue This Year
- ADT $6.22
- IRTC $25.19
- Revenue Next Year
- ADT $4.32
- IRTC $17.01
- P/E Ratio
- ADT $12.83
- IRTC N/A
- Revenue Growth
- ADT 6.58
- IRTC 22.37
- 52 Week Low
- ADT $6.71
- IRTC $67.92
- 52 Week High
- ADT $8.94
- IRTC $188.53
- Technical
- Relative Strength Index (RSI)
- ADT 48.24
- IRTC 60.06
- Support Level
- ADT $8.39
- IRTC $179.93
- Resistance Level
- ADT $8.85
- IRTC $187.96
- Average True Range (ATR)
- ADT 0.12
- IRTC 5.33
- MACD
- ADT 0.01
- IRTC 0.13
- Stochastic Oscillator
- ADT 52.75
- IRTC 68.56
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.